Latest market price
152.05
-3.93-2.52%
OverviewShort InterestFilings
XBIState Street SPDR S&P Biotech ETF·AMEX
152.05-2.52%
TA
Loading chart...
Screen all →
VXUS+0.27%$82.59VUG-1.21%$84.03VTV+0.24%$228.57VO+0.25%$81.66VGT-2.68%$113.83VB+0.60%$291.80VWO+0.34%$55.70VIG+0.19%$248.24
Fund Snapshot
Category—Asset TypeEquityTagshealthcareReturn% 1Y35.35%Total Holdings165Perf Week1.05%
SponsorSPDRETF TypeTagssectorReturn% 3Y33.59%AUM$10.76BPerf Month-1.54%
Fund FamilyBond TypeTags—Return% 5Y4.27%NAV/shPerf Quarter0.11%
Index—Average MaturityTags—Return% 10Y52W High169.89 -10.50%Perf Half Y13.90%
Index WeightingCommodity TypeTags—Return% SI52W Low106.30 43.04%Perf YTD24.70%
Active/PassiveQuant TypeTags—Flows% 1M0.00%Volatility3.25% 2.95%Perf Year35.87%
Dividend TTM0.54 (0.36%)ESG TypeTags—Flows% 3M0.00%ATR (14)4.51Perf 3Y129.75%
Dividend Ex-DateJun 22, 2026Dividend TypeSector/ThemeFlows% YTD-14.80%RSI (14)47.82Perf 5Y22.24%
Dividend Gr. 3/5Y—Structure TypeRegionFlows% 1YBeta0.84Perf 10Y154.56%
Expense0.35%Growth/ValueSMA200.46%Flows% 3YRel Volume0.85Prev Close155.98
Inverse/LeveragedMarket CapSMA50-2.74%Flows% 5YAvg Volume8.97MPrice152.05
IPO DateJan 31, 2006Option/ShortYes / YesSMA2007.24%52W Range %72%Volume7,666,065Change-2.52%
Holdings Breakdown
View Holdings as
Stocks
99.3%Healthcare
0.7%Financial Services
Assets Under Management
02.50B5.00B7.50B10.00BAprJunAugOct'25MarMayJulSepNov'26MarMayJulSepNov
● Assets Under Management
Latest News· Times ET
Nov-02-26
Nov-02-2602:54PM
Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge247wallst.com
Oct-30-26
Oct-30-2611:18AM
Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs247wallst.com
Oct-28-26
Oct-28-2612:11PM
ETFs That You May Consider Amid a Strengthening Biotech Outlookzacks.com
07:20AM
What The U.S. Midterm Elections Mean For Healthcare And PharmaSeekingAlpha
Oct-26-26
Oct-26-2607:21AM
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)?zacks.com
Oct-22-26
Oct-22-2605:30AM
Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy?fool.com
Oct-20-26
Oct-20-2604:48AM
Why $55 Million Flowed Into a Triple-Leveraged Biotech ETF Worth Less Than $600 MillionYahoo
Oct-18-26
Oct-18-2604:25AM
SPDR S&P Biotech ETF $XBI Stock Sold by Banque Pictet & Cie SAdefenseworld.net
Oct-16-26
Oct-16-2603:41AM
Traders Purchase Large Volume of Call Options on SPDR S&P Biotech ETF (NYSEARCA:XBI)defenseworld.net
Oct-14-26
Oct-14-2601:37AM
UNH Stock Outpaces S&P 500 In 2026, Eyes Best Year Since Pandemic — CFO Says Wall Street May Be Missing 2027 UpsideYahoo
Oct-13-26
Oct-13-2610:21AM
From Laggard to Leader: The Surprising Comeback of Healthcareetftrends.com
Oct-12-26
Oct-12-2602:33PM
Biotech's Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticismetftrends.com
Oct-08-26
Oct-08-2607:05AM
SPDR S&P Biotech ETF $XBI Stock Acquired by Ayalon Insurance Comp Ltd.defenseworld.net
Oct-07-26
Oct-07-2609:10AM
Market Concentration: Building For More Than One OutcomeSeekingAlpha
Oct-05-26
Oct-05-2601:41AM
Better Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting Biotechfool.com
Fund

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR